However, it should be emphasized that none of the EGFR-targeted therapies have shown promising results in clinical trials in patients with glioma, so these positive results of the work on the combination of PDT with EGFR inhibitors should be treated with caution and need to be confirmed clinically [285]. This evidence concerns the gene EGFR and central nervous system cancer.